Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2010
10/05/2010US7807364 determining whether a patient will respond to anti-VEGF antibody based chemotherapy by screening suitable cell or tissue sample from the patient for at least one genomic polymorphism or genotype; using a bevacizumab antibody or an antibody that binds to the same epitope on VEGF and and cyclophosphamide
10/05/2010US7807363 Measuring the expression level of a gene which comprises a nucleotide sequence homologous to the sequence of SEQ ID NO:1;diagnosing or monitoring elevated intraocular pressure or glaucoma
10/05/2010US7807362 Diagnosis of attention deficit hyperactivity disorder
10/05/2010US7807361 Dairy cattle breeding for improved milk production traits in cattle
10/05/2010US7807360 comprises a micro chamber having a hydrophilic functional group disposed on an interior surface of the micro chamber, a kosmotropic salt solution storing par, a polymerase chain reaction (PCR) mixture storing part, a heating part and cooling part; minimizes sample loss, time and cost
10/05/2010US7807359 rapid and simultaneous screening of one or more samples for one or more mutations in the Thiopurine S-methyltransferase (TPMT) gene of an individual; used to design an appropriate therapy using drugs metabolized by TPMT for that individual
10/05/2010US7807358 High-throughput methods for detecting DNA methylation
10/05/2010US7807357 for detecting the presence of the transgene/genomic insertion region; for transgenic glyphosate tolerance; genetic engineering
10/05/2010US7807356 For analysis of ligated RNA; employed in methods for labeling RNA by contacting a sample containing RNA with an enzyme having an RNA ligation activity in the presence of the labeled nucleotide composition
10/05/2010US7807355 drug screening; identifying a therapeutic for decreasing intraocular pressure raised due to frizzled related protein (FRP) overexpression; contacting a trabecular meshwork cell expressing a Wnt pathway component or a frizzled related protein gene product with a test compound
10/05/2010US7807354 Low volume hybridization
10/05/2010US7807353 hypoxanthine-guanine phosphoribosyltransferase gene; measuring a difference in levels of expression of a desired gene in two or more kinds of test samples
10/05/2010US7807352 Using microarray comprising immobolized biopolymers which utilizes universal detection elements as tool for identifying preferential compounds
10/05/2010US7807351 Probe complex for use in detection of severe acute respiratory syndrome corna virus and/or salmonella
10/05/2010US7807350 Methods for predicting irinotecan toxicity
10/05/2010US7807349 by ribosomes in real time; binding a first label to a ribosome to form a donor fluorophore, binding a second label to tRNA to form an acceptor fluorophore, detecting electromagnetic radiation signals emitted when the two labels are in proximity
10/05/2010US7807347 Immuno-PCR method for detecting nasopharyngeal carcinoma markers and kit thereof
10/05/2010US7807346 Using fusion protein comprised of terminal reporter molecules to rapidly detect virus binding and entry into cells; receptor-dependent targeted therapy; viricides
10/05/2010US7807345 Kit which utilizes 5' untranslated region of viral sequences as probe in detection of viral infection
10/05/2010US7807344 Methods and systems for ensuring the security of grain stores
10/05/2010US7807180 inducing an immune response to a poxvirus in a mammal by administering a composition comprising a nucleic acid molecule comprising nucleotide sequence encoding a variola F8 polypeptide, wherein nucleotide sequence is codon optimized for expression in both a mammalian cell and a bacterial cell
10/05/2010US7807145 Method of inducing neuronal production in the brain and spinal cord
10/05/2010US7807106 Apparatus and method to measure platelet contractility
10/05/2010US7807103 Allergen detection apparatus
10/05/2010US7807043 determining the concentration of the analyte in the fluid sample; manufacturing the devices; using a biosensor and calculates the glucose concentration in the patient's blood; monitoring by diabetic patient
10/05/2010CA2587548C Method for determining genotoxicity
10/05/2010CA2530798C Synthesis and compositions of 2'-terminator nucleotides
10/05/2010CA2389533C Methods and compositions for detection of mycobacterium avium complex species
10/05/2010CA2298438C Synthetic antigen for the detection of antibodies immunoreactive with hiv virus
10/05/2010CA2086325C Ligand for cd28 receptor on b cells and methods
09/2010
09/30/2010WO2010111691A2 Conjugates of biomolecules to nanoparticles
09/30/2010WO2010111690A2 Polymerase compositions and methods
09/30/2010WO2010111686A2 Labeled enzyme compositions, methods & systems
09/30/2010WO2010111682A2 Methods, compositions, and kits for detecting allelic variants
09/30/2010WO2010111674A2 Methods and apparatus for single molecule sequencing using energy transfer detection
09/30/2010WO2010111656A2 Systems and methods for assessing images
09/30/2010WO2010111605A2 Devices and methods for analyzing biomolecules and probes bound thereto
09/30/2010WO2010111600A1 Polymorphism in cyp3a4 gene affecting drug metabolizing and uses thereof
09/30/2010WO2010111595A2 Markers related to age-related macular degeneration and uses therefor
09/30/2010WO2010111509A1 Discriminatory positive/extraction control dna
09/30/2010WO2010111494A1 Single molecule sensitive probes for detecting rna
09/30/2010WO2010111467A1 Hiv vpr-specific t cell receptors
09/30/2010WO2010111388A2 Devices and methods of cell capture and analysis
09/30/2010WO2010111361A1 Biomarkers for assessing peripheral neuropathy response to treatment with a proteasome inhibitor
09/30/2010WO2010111208A1 Mitochondrial inhibitors and uses thereof
09/30/2010WO2010110945A1 System and methods for determination of analyte concentration using time resolved amperometry
09/30/2010WO2010110929A2 Methods for simultaneous generation of functional ligands
09/30/2010WO2010110914A2 Mammalian genes involved in infection
09/30/2010WO2010110835A1 Pcr methods for characterizing the 5' untranslated region of the fmr1 and fmr2 genes
09/30/2010WO2010110749A1 Method of loading nucleic acids to noble metal surfaces
09/30/2010WO2010110741A1 Apparatus and method for detection of organisms
09/30/2010WO2010110373A1 Gene marker linked to genetic sex of yellowtail, sex determination method for yellowtail, and primer for use in sex determination method
09/30/2010WO2010110346A1 Leukemia stem cell markers
09/30/2010WO2010110096A1 Reaction optical measurement device and method for measurement therefor
09/30/2010WO2010109511A1 Use of microrna-199b-5p in medical and diagnostic field
09/30/2010WO2010109463A2 Methods of predicting pairability and secondary structures of rna molecules
09/30/2010WO2010109451A1 Diagnosis of bacillus anthracis infection based on detection of bacterial secreted biomarkers
09/30/2010WO2010109197A2 Method
09/30/2010WO2010109173A1 A microbiological detection method
09/30/2010WO2010109065A1 Luminescence assay method
09/30/2010WO2010109009A1 Methods for the detection and treatment of aberrant prion disease
09/30/2010WO2010108926A1 Method for diagnosing or predicting a non syndromic autosomal recessive optic atrophy, or a risk of a non syndromic autosomal recessive optic atrophy.
09/30/2010WO2010108831A1 Genotyping of bovine papillomavirus genotypes
09/30/2010WO2010108759A1 Helicobacter pylori sensor
09/30/2010WO2010108737A1 Method for determining the predisposition of a patient to changed biotransformation and to the development of undesired pharmaceutical effects in a treatment of the patient with atorvastatin
09/30/2010WO2010108638A1 Tumour gene profile
09/30/2010WO2010108498A1 Genetic markers for mastitis resistance
09/30/2010WO2010108325A1 Loop-shaped primer employed in nucleic acid amplification and the use thereof
09/30/2010WO2010108275A1 Method and apparatus for predicting susceptibility to a developmental disorder
09/30/2010WO2010091023A3 Indexing a reference sequence for oligomer sequence mapping
09/30/2010WO2010082004A9 Methods for determining the likelihood of a patient contracting a nosocomial infection and for determining the prognosis of the course of a septic syndrome
09/30/2010WO2010068702A3 Methods and compositions for hybridizing nucleic acids
09/30/2010WO2010065671A3 Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf
09/30/2010WO2010065662A3 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirtuin 1
09/30/2010WO2010065629A3 Nucleic acid amplification
09/30/2010WO2010059970A3 Compositions for detecting human interferon-alpha subtypes and methods of use
09/30/2010WO2010059914A3 Nucleic acid quantification products and processes
09/30/2010WO2010059051A3 Rapid fret-based diagnosis of bacterial pathogen
09/30/2010WO2010059006A3 MEMS CHIP FOR CHROMATIN IMMUNOPRECIPITATION (ChIP) AND CHIP METHOD USING SAME
09/30/2010WO2010056993A3 Prostate cancer biomarkers to predict recurrence and metastatic potential
09/30/2010WO2010056858A3 Bioluminescence imaging-based screening assay and inhibitors of abcg2
09/30/2010WO2010056012A3 Method for quantifying skin changes caused by six external evils and method for screening skin condition-improving materials using the same
09/30/2010WO2010055488A3 Compositions and methods for micro-rna expession profiling of hepatocellular cancer
09/30/2010WO2010055487A3 Compositions and methods for micro-rna expession profiling of colorectal cancer
09/30/2010WO2010054379A3 Gene signature for predicting prognosis of patients with solid tumors
09/30/2010WO2010048710A8 Neurotoxic sterol glycosides
09/30/2010WO2010048337A3 Preservation of information related to genomic dna methylation
09/30/2010WO2010041149A3 Methods and compositions for diagnosis and treatment of autoimmune disease secondary to multiple sclerosis
09/30/2010WO2010036960A3 Methods for treating, diagnosing, and monitoring lupus
09/30/2010WO2009143624A8 Methods of diagnosing rejection of a kidney allograft using genomic or proteomic expression profiling
09/30/2010WO2006050499A3 Single step detection assay
09/30/2010US20100251428 Compositions And Methods For Conversion Of Aldehydes To Alkanes
09/30/2010US20100251416 Plants with increased tolerance and/or resistance to environmental stress and increased biomass production
09/30/2010US20100251415 Composition and Method for Modulating Plant Transformation
09/30/2010US20100251414 Pea line 08270930
09/30/2010US20100251396 Transgenic mice expressing human formyl peptide receptor
09/30/2010US20100251392 Methods for assessing the delivery of exogenous agents
09/30/2010US20100249427 Bioluminescent protease assay
09/30/2010US20100249375 Immobilizing molecules on a solid support
09/30/2010US20100249373 Screening methods
1 ... 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 ... 3003